Modeling Cardiovascular Protection With SGLT Inhibition in Type 1 Diabetes: A Risk-Based Approach to Guide Therapy?
- PMID: 40100966
- DOI: 10.2337/dc24-2840
Modeling Cardiovascular Protection With SGLT Inhibition in Type 1 Diabetes: A Risk-Based Approach to Guide Therapy?
Publication types
LinkOut - more resources
Full Text Sources
